Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) EBT (2016 - 2025)

Harte Hanks (HHS) has disclosed EBT for 16 consecutive years, with -$413000.0 as the latest value for Q2 2025.

  • On a quarterly basis, EBT fell 130.96% to -$413000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $67000.0, a 90.92% decrease, with the full-year FY2024 number at -$37.9 million, down 1876.76% from a year prior.
  • EBT was -$413000.0 for Q2 2025 at Harte Hanks, up from -$1.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $10.8 million in Q2 2021 to a low of -$3.9 million in Q4 2023.
  • A 5-year average of $2.1 million and a median of $1.7 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: surged 425.54% in 2022, then plummeted 297.6% in 2023.
  • Harte Hanks' EBT stood at $2.0 million in 2021, then fell by 1.43% to $2.0 million in 2022, then tumbled by 297.6% to -$3.9 million in 2023, then surged by 52.76% to -$1.9 million in 2024, then surged by 77.84% to -$413000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's EBT are -$413000.0 (Q2 2025), -$1.9 million (Q4 2024), and $1.0 million (Q3 2024).